Brain PET-MRI Systems Market Size, Share & Trends Analysis Report By Phase (Clinical, Pre-Clinical), By Product (Traditional Systems, Helium Free Systems), By End-use, By Region, And Segment Forecasts, 2024 - 2030

Brain PET-MRI Systems Market Trends

The global brain PET-MRI systems market size was valued at USD 343.0 million in 2023 and is expected to grow at a CAGR of 6.0% from 2024 to 2030. Positron emission tomography is mainly used in neurology for its ability to provide high-resolution, 3D images of functional, physiological, and molecular targets. PET scanners are frequently integrated with other imaging modalities, particularly MRI, to ensure precise alignment with anatomical structures and pathological alterations.

The combination of MRI and PET is widely recognized as a highly efficient hybrid imaging technology in the neurology field. The capability of magnetic resonance imaging (MRI) to depict the brain's structure, along with its ability to assess physiological and metabolic aspects such as perfusion, edema, vascular supply, and functional activation, enhances its appeal when used in conjunction with PET Systems. Consequently, the combined data from the MRI and PET hybrid imaging Systems plays a crucial role in improving the diagnosis of neurological conditions.

PET-MRI systems for the brain have created new possibilities for multi parametric neuroimaging by observing the physiological and biochemical processes of the brain simultaneously. Consequently, there is a growing trend of installing these devices in various medical settings. According to an article by NCBI, as of March 2018, around 30 PET MRI scanners had been installed in the U.S. Furthermore, companies are conducting research to assess the efficacy of MRI-PET scanners in both animal and human subjects.

The use of brain PET-MRI systems in preclinical imaging is on the rise, creating opportunities for new entrants in the market. There has been a significant global push to enhance the resolution of MRI for studying the human brain, resulting in the development of an ultra-high resolution 7 Tesla scanner. This scanner can capture up to 10 times more detail than current 7T scanners and over 50 times more detail than current 3T scanners, which are widely used in most hospitals. The enhanced clarity allows scientists to observe fMRI features that are 0.4 millimeters in size, as opposed to the usual 2 or 3 millimeters seen in current standard 3T fMRIs.

Phase Insights

The pre-clinical brain PET-MRI systems segment accounted for the largest revenue share of 58.0% in 2023. With numerous pre-clinical studies being carried out on this device to determine its effectiveness in diagnosing neurological disorders, market players are now focusing on the development of pre-clinical brain PET-MRI systems to either penetrate the brain PET-MRI systems market or uphold their current position in the market.  

The clinical brain PET-MRI systems segment is expected to witness a CAGR of 6.3% over the forecast period. The clinical brain PET-MRI system is anticipated to witness significant growth owing to several factors including the increasing frequency of neurological disorders such as Alzheimer’s disease and brain tumors. PET-MRI provides the complementary anatomic, physiologic, metabolic, and functional information about the brain. Simultaneous PET/MRI allows for both spatial and temporal correlation of the signals, creating opportunities impossible to realize using sequentially acquired data.

Product Insights

Traditional PET-MRI systems held the largest revenue share of 60.4% in 2023 due to the growing development of these devices by the market players. Traditional brain PET-MRI systems developed by prominent players such as Siemens Healthcare, GE Healthcare, and Bruker require the use of helium for magnet cooling.

Helium-free brain PET-MRI systems are expected to grow at the fastest CAGR of 6.3% in the coming years. Companies are concentrating on developing pre-clinical brain PET-MRI systems without helium to assess their impact on neurology.

End-use Insights

Hospitals held the largest revenue share of 42.0% in 2023 owing to an increasing number of neurological disorders and brain imaging, as these procedures require advanced and costly equipment that is usually only available in hospital settings. Every year, about 500,000 cases of amyotrophic lateral sclerosis, brain tumors, and multiple sclerosis are diagnosed. The need for neurological diagnosis is being influenced by the increase in neurological cases. As a result, hospitals are consistently installing brain PET-MRI equipment to improve the diagnosis of neurological diseases.

The diagnostic imaging centers is expected to grow at a fastest CAGR of 6.2% over the forecast period. The growth in diagnostic imaging centers is driven by growing aging population and subsequent rise in chronic disease. According to a report by GLOBOCAN,there were 9.7 million deaths in 2022 and 20 million new cancer cases, 1 in 9 men and 1 in 12 women are expected to die from cancer.

Regional Insights

North America held the largest revenue share of 30.4% in 2023 owing to the increasing adoption of advanced diagnostic machines in research centers and universities established in the region including advanced healthcare infrastructure, high healthcare expenditure, extensive research and development activities, and the presence of leading neuroimaging technology manufacturers and research institutions.

U.S. Brain PET-MRI Systems Market Trends

The Brain PET-MRI systems market in the U.S. dominated the market with a share of 80.0% in 2023 due to advancement in technology, high demand for healthcare services, including diagnostic imaging, and is home to various research and developments including institutions, universities, and medical centers engaged in neuroscience research.

Europe Brain PET-MRI Systems Market Trends

Europe brain PET-MRI systems market was identified lucrative region in 2023.Growing awareness regarding hybrid imaging in the region is expected to drive the adoption of brain PET-MRI systems in the region for applications such as neurology.

The UK brain PET-MRI systems market is expected to grow rapidly in the coming years owing to rising burden of neurological disease and the aging population in the UK. Further, the technological advancements in UK play a crucial role in brain PET-MRI market growth.

Germany held a substantial share in 2023 owing to country’s advanced healthcare infrastructure, support from government and more focused on research and development and the growing awareness among healthcare professionals and patients.

Asia Pacific Brain PET-MRI Systems Market Trends

Asia Pacific held a significant revenue share of 28.13% in 2023 owing to the growing prevalence of neurological disorders in the region. The Asia Pacific is expected to grow at a fastest rate, this can be attributed to a rise in the utilization of advanced diagnostic machines within research centers and universities, fueling the market growth.

The China brain PET-MRI systems market is expected to grow rapidly in the coming years. This can be attributed to the presence of aging increasing population and growth of prevalence of chronic diseases, such as cancer, Alzheimer are anticipated to promote market growth.  Increasing road accidents is anticipated to drive the market during the forecast period.

Brain PET-MRI systems market in India is projected to grow in the coming years owing to rising healthcare expenditure, growing disease burden for instance, disorders like Alzheimer’s disease and dementia.

Key Brain PET-MRI Systems Company Insights

Market participants are currently engaging in collaborations and partnerships to broaden their range of products and extend the reach of their offerings. In September 2022, The Arctic University of Norway successfully developed a deep learning-based artificial intelligence system for quantitative PET imaging, utilizing MR Solutions' state-of-the-art simultaneous 7T PET/MR dry magnet technology.

Recent Developments

• In February 2024, Philips announced the launch of smart quant neuro 3D, an AI based quantitative brain imaging in MR. the recent launched product offers powerful tools for greater diagnostics confidence to healthcare providers.

• In June 2023, GE Healthcare announced to unveil its signa PET/MRI AIR technologies for enhancing images. GE healthcare to unveil recent launched signa at the society of nuclear medicine and molecular imaging 2023 annual meeting in Canada.

Brain PET-MRI Systems Market Report Scope

Global Brain PET-MRI Systems Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global brain PET-MRI systems market report on the basis of phase, product, end-use, and region:

• Phase Outlook (Revenue, USD Million, 2018 - 2030)

  • Clinical

  • Pre-clinical

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Traditional PET-MRI systems

  • Helium-free PET-MRI systems

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Diagnostic imaging centers

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • U.K.

    • France

    • Italy

    • Spain

    •  Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • Thailand

    • South Korea

    •  Australia

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait